| 查看: 2052 | 回复: 8 | ||||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | ||||
[交流]
关于Biomaterials投稿
|
||||
|
第一次投Biomaterials,有好多问题不是太懂,谁投过给些建议。 1.实验数据是不是放在文章的最后面 2.A template for the covering letter is found on the Biomaterials website.我没找到,想问一下你们在哪找到的 |
» 猜你喜欢
博士读完未来一定会好吗
已经有16人回复
心脉受损
已经有5人回复
Springer期刊投稿求助
已经有4人回复
读博
已经有3人回复
小论文投稿
已经有3人回复
Bioresource Technology期刊,第一次返修的时候被退回好几次了
已经有9人回复
到新单位后,换了新的研究方向,没有团队,持续积累2区以上论文,能申请到面上吗
已经有8人回复
申请2026年博士
已经有6人回复
» 本主题相关价值贴推荐,对您同样有帮助:
关于一篇文献的题目
已经有5人回复
2012 SCI impact factor 生物材料类 评点
已经有9人回复
论文投稿刊物选择
已经有1人回复
» 抢金币啦!回帖就可以得到:
Ei期刊青年编委招募(工程设计方向)
+1/376
哈工深国家级青年人才王龙龙教授团队—诚招新能源电池方向博士和硕士研究生
+1/197
哈尔滨工业大学深圳校区—国家级青年人才王龙龙教授团队—诚聘新能源电池方向博士后
+1/194
坐标广州,征女友
+2/100
华北电力大学机械工程系输电线路工程方向招聘优秀青年人才或师资博士后
+2/100
转录组数据求助
+1/91
天津大学精密测试技术及仪器全国重点实验室柔性电子技术实验室专任副研究员招聘启事
+1/75
2026申博自荐
+1/47
校长团队招博士生和博士后
+1/30
长春理工大学和西安工业大学主动光电探测成像技术重点实验室招收博士生
+1/12
SCI文章辅助,计算机网络通信方向
+1/10
SCI文章辅助,计算机网络通信方向
+1/7
海南大学国家高层次人才团队2026年博士招生
+1/6
北京科技大学/李亚庚教授/优青/招收2026年秋季入学博士生1名
+1/5
荷兰奈梅亨大学招收2026 CSC博士: 非线性控制与神经调控
+1/4
湖南大学招收锂离子电池、离子液体、高分子与凝胶材料、电催化方向博士生多名
+1/4
CSC 因斯布鲁克大学计算机系 联培/攻博
+1/3
北理工柔性电子国家杰青团队招【博士后】【科研助理(读博意向)】
+1/3
西湖大学李小波课题组诚聘博士后3名(生物学方向)
+1/2
华中农业大学生命科学技术学院 “酶智能设计与农药生物合成”课题组招聘启事
+1/2
5楼2012-11-18 09:19:31
nono2009
超级版主 (文学泰斗)
-

专家经验: +21105 - SEPI: 10
- 应助: 28684 (院士)
- 贵宾: 513.911
- 金币: 2555170
- 帖子: 1602247
- 在线: 65200.8小时
- 虫号: 827383
★ ★
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+1 2012-11-18 09:04:24
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+1 2012-11-18 09:04:24
|
楼主是看的这里吗:http://www.elsevier.com/journals ... 2/guide-for-authors 这么没有查到你说的A template for the covering letter is found on the Biomaterials website |
2楼2012-11-17 19:30:02
3楼2012-11-17 22:01:53
★ ★ ★ ★ ★ ★
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+5 2012-11-18 09:19:43
esub: 回帖置顶 2013-04-24 17:07:15
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+5 2012-11-18 09:19:43
esub: 回帖置顶 2013-04-24 17:07:15
|
亲,你可以在EES的主页上的右边栏上点Author declaration,然后就会直接下载一个word版本的author declaration,而 A template for the covering letter will be found at the end of this document:顺便给你复制了一个,因为好还不会用附件啊 We the undersigned declare that this manuscript is original, has not been published before and is not currently being considered for publication elsewhere. We would like to draw the attention of the Editor to the following publications of one or more of us that refer to aspects of the manuscript presently being submitted. Where relevant copies of such publications are attached. [CAN BE DELETED IF NOT RELEVANT] We wish to draw the attention of the Editor to the following facts which may be considered as potential conflicts of interest and to significant financial contributions to this work. [OR] We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us. We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In so doing we confirm that we have followed the regulations of our institutions concerning intellectual property. We further confirm that any aspect of the work covered in this manuscript that has involved either experimental animals or human patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript. [CAN BE DELETED IF NOT RELEVANT] We understand that the Corresponding Author is the sole contact for the Editorial process (including Editorial Manager and direct communications with the office). He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author and which has been configured to accept email from biomaterials@online.be. Signed by all authors as follows: [LIST AUTHORS AND DATED SIGNATURES ALONGSIDE] |
4楼2012-11-17 22:38:10













回复此楼